Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group.
Provencio M, Cruz Mora MÁ, Gómez-Codina J, Quero Blanco C, Llanos M, García-Arroyo FR, de la Cruz L, Gumá Padró J, Delgado Pérez JR, Sánchez A, Alvarez Cabellos R, Rueda A; Gotel (Spanish Lymphoma Oncology Group). Provencio M, et al. Among authors: llanos m. Leuk Lymphoma. 2014 Jan;55(1):51-5. doi: 10.3109/10428194.2013.790544. Epub 2013 Jun 12. Leuk Lymphoma. 2014. PMID: 23573825 Clinical Trial.
Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series.
Guisado-Vasco P, Arranz-Saez R, Canales M, Cánovas A, Garcia-Laraña J, García-Sanz R, Lopez A, López JL, Llanos M, Moraleda JM, Rodriguez J, Rayón C, Sabin P, Salar A, Marín-Niebla A, Morente M, Sánchez-Godoy P, Tomás JF, Muriel A, Abraira V, Piris MA, Garcia JF, Montalban C; Spanish Hodgkin Lymphoma Study Group. Guisado-Vasco P, et al. Among authors: llanos m. Leuk Lymphoma. 2012 May;53(5):812-9. doi: 10.3109/10428194.2011.635861. Epub 2012 Jan 31. Leuk Lymphoma. 2012. PMID: 22185637
Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?
Provencio M, Sabín P, Gómez Codina J, Rueda A, Llanos M, Gumá J, Quero Blanco C, Blasco A, Delgado JR, Cruz MÁ, Aguiar D, García-Arroyo FR, Herrero J, Lavernia J, Martínez Banaclocha N, Morales M, Fuster J, Sáez Cusi Á, Lobo F, Rodríguez Abreu D, de la Cruz L, Antón E, Rodríguez Jiménez A, Arízcun A, Pérez X; GOTEL (Spanish Lymphoma Oncology Group). Provencio M, et al. Among authors: llanos m. Clin Transl Oncol. 2012 May;14(5):386-90. doi: 10.1007/s12094-012-0813-3. Clin Transl Oncol. 2012. PMID: 22551546
High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma.
Rueda A, Rifá J, Quero C, Gómez-Codina J, Murias A, García-Arroyo FR, Sabín P, Llanos M, Herrero J, Lobo F, Delgado JR, Provencio M; Spanish Lymphoma Oncology Group. Rueda A, et al. Among authors: llanos m. Leuk Lymphoma. 2014 Jun;55(6):1413-6. doi: 10.3109/10428194.2013.836601. Epub 2013 Oct 9. Leuk Lymphoma. 2014. PMID: 23964649 No abstract available.
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis.
Montes-Moreno S, Batlle A, de Villambrosía SG, Sánchez-Espiridión B, Cereceda L, González-Barca E, Purroy N, Pardal E, Martín A, Grande C, Mazorra F, Insunza A, Quero C, Aguiar D, Cruz MA, Rueda A, Llanos M, Codina JG, Arroyo FR, Caballero D, Conde E, López A, Provencio M, Piris M. Montes-Moreno S, et al. Among authors: llanos m. Haematologica. 2014 Aug;99(8):e138-41. doi: 10.3324/haematol.2014.104976. Epub 2014 Apr 24. Haematologica. 2014. PMID: 24763400 Free PMC article. Clinical Trial. No abstract available.
Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group.
Franco Pérez F, Lavernia J, Aguiar-Bujanda D, Miramón J, Gumá J, Álvarez R, Gómez-Codina J, Arroyo FG, Llanos M, Marin M, Alfaro J, Quero C, Delgado M, Nogales E, Menarguez F, Martinez N, Torrente M, Royuela A, Abreu D, Provencio M. Franco Pérez F, et al. Among authors: llanos m. Clin Lymphoma Myeloma Leuk. 2017 Mar;17(3):186-191. doi: 10.1016/j.clml.2016.09.004. Epub 2016 Sep 17. Clin Lymphoma Myeloma Leuk. 2017. PMID: 27847267 Free article.
Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry.
Provencio M, Sabín P, Gomez-Codina J, Torrente M, Calvo V, Llanos M, Gumá J, Quero C, Blasco A, Cruz MA, Aguiar D, García-Arroyo F, Lavernia J, Martinez N, Morales M, Saez-Cusi A, Rodriguez D, de la Cruz L, Sanchez JJ, Rueda A; GOTEL (Spanish Lymphoma Oncology Group). Provencio M, et al. Among authors: llanos m. PLoS One. 2017 May 11;12(5):e0177204. doi: 10.1371/journal.pone.0177204. eCollection 2017. PLoS One. 2017. PMID: 28493986 Free PMC article.
155 results